Suppr超能文献

通过 CRISPR-Cas9 和 phiC31 整合酶实现瞬时视觉基因分型和简便的位点特异性转基因。

Instantaneous visual genotyping and facile site-specific transgenesis via CRISPR-Cas9 and phiC31 integrase.

机构信息

Department of Basic Medical Science, Quanzhou Medical College, Quanzhou, Fujian 362011, China.

Cardiovascular Research Center, Massachusetts General Hospital, Charlestown, MA 02129, USA and Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.

出版信息

Biol Open. 2024 Sep 15;13(9). doi: 10.1242/bio.061666. Epub 2024 Sep 3.

Abstract

Here, we introduce 'TICIT', targeted integration by CRISPR-Cas9 and integrase technologies, which utilizes the site-specific DNA recombinase - phiC31 integrase - to insert large DNA fragments into CRISPR-Cas9 target loci. This technique, which relies on first knocking in a 39-basepair phiC31 landing site via CRISPR-Cas9, enables researchers to repeatedly perform site-specific transgenesis at the exact genomic location with high precision and efficiency. We applied this approach to devise a method for the instantaneous determination of a zebrafish's genotype simply by examining its color. When a zebrafish mutant line must be propagated as heterozygotes due to homozygous lethality, employing this method allows facile identification of a population of homozygous mutant embryos even before the mutant phenotypes manifest. Thus, it should facilitate various downstream applications, such as large-scale chemical screens. We demonstrated that TICIT could also create reporter fish driven by an endogenous promoter. Further, we identified a landing site in the tyrosinase gene that could support transgene expression in a broad spectrum of tissue and cell types. In sum, TICIT enables site-specific DNA integration without requiring complex donor DNA construction. It can yield consistent transgene expression, facilitate diverse applications in zebrafish, and may be applicable to cells in culture and other model organisms.

摘要

在这里,我们介绍了“TICIT”,即 CRISPR-Cas9 和整合酶技术靶向整合,它利用位点特异性 DNA 重组酶——phiC31 整合酶——将大片段 DNA 插入 CRISPR-Cas9 靶位点。该技术依赖于首先通过 CRISPR-Cas9 敲入一个 39 碱基对的 phiC31 着陆位点,使研究人员能够在精确的基因组位置上以高精度和高效率重复进行位点特异性转基因操作。我们应用这种方法设计了一种方法,可以通过简单地检查其颜色来立即确定斑马鱼的基因型。当由于纯合致死性而必须将斑马鱼突变系作为杂合子进行繁殖时,使用这种方法可以在突变表型出现之前轻松鉴定出一群纯合突变胚胎。因此,它应该促进各种下游应用,如大规模化学筛选。我们证明 TICIT 还可以创建由内源性启动子驱动的报告鱼。此外,我们在酪氨酸酶基因中鉴定了一个着陆位点,该位点可以在广泛的组织和细胞类型中支持转基因表达。总之,TICIT 能够实现无需复杂供体 DNA 构建的位点特异性 DNA 整合。它可以产生一致的转基因表达,促进斑马鱼的多种应用,并且可能适用于培养细胞和其他模式生物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ce1/11391820/6ae134183af6/biolopen-13-061666-g1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验